1. Subortseva I.N., Melikyan A.L. Chabaeva Yu.A. et al. Preliminary results of the Register of patients with myelofibrosis and polycythemia vera with constitutional symptoms in routine clinical practice in the Russian Federation. Gematologiya i transfuziologiya = Hematology and Transfusiology 2022;67(2):305. (In Russ.).
2. Melikyan A., Subortseva I., Baryshniikova D. et al. Epidemiological, clinical, molecular and genetic characteristics of primary myelofibrosis in the Russian Federation. HemaSphere 2019;3(S1):994–5.
3. Abdulkadyrov K.M., Shuvaev V.A., Martynkevich I.S. Myeloproliferative neoplasms. Saint Petersburg: Litterra; Moscow: Litterra, 2016. 298 p. (In Russ.).
4. Orphanet. Prevalence of rare diseases: Bibliographic data. In: Orphanet Report Series, Rare Diseases Collection. Ed.: C. Gonthier. 2011. P. 13.
5. Arber D.A., Orazi A., Hasserjian R. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127(20):2391–405. DOI: 10.1182/blood201603643544